Showing results (51-60 of 140) with videos related to
Sort By:
Pageof 14
Medical Mycology|January 31, 2022
Comparative evaluation of Sensititre YeastOne and VITEK 2 against the Clinical and Laboratory Standards Institute M27-E4 reference broth microdilution method for the antifungal susceptibility testing of Cryptococcus neoformans and Cryptococcus gattiiMin Zhang, Ziyi Zhou, Dongjiang Wang, et al.Cancer Management and Research|March 10, 2021
Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective StudyWen Zhang, Yong Li, Liyan Xue, et al.Asia-Pacific Journal of Clinical Oncology|January 24, 2023
Less aggressive treatment for less aggressive disease? A retrospective single-center study of pulmonary-limited metastases associated with colorectal cancerWang Qu, Yongkun Sun, Wen Zhang, et al.BMC Cancer|December 7, 2025
The nasopharyngeal carcinoma in Xiamen China from 2011 to 2020: a population-based linkage studyJiali Quan, Aiping Zhou, Zhinan Guo, et al.Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|May 8, 2023
[Advances in genomics of multi-drug resistant Stenotrophomonas]Yuhang Tang, Shiqi Fang, Linlin Xie, et al.Infection and Drug Resistance|March 18, 2024
Antimicrobial Resistance and Molecular Characterization of Salmonella Rissen Isolated in China During 2008-2019Lili Wang, Lu Nie, Yue Liu, et al.Microorganisms|August 29, 2024
Potential Convergence to Accommodate Pathogenicity Determinants and Antibiotic Resistance Revealed in Salmonella MbandakaNa Lv, Jinjing Ni, Shiqi Fang, et al.Cancer Chemotherapy and Pharmacology|September 18, 2013
Phase I study of the safety, pharmacokinetics and antitumor activity of famitinibAiping Zhou, Wen Zhang, Chunxiao Chang, et al.Frontiers in Oncology|May 6, 2022
Different Radiological Criteria for Early Tumor Response Evaluation in Patients With Unresectable Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody Plus BevacizumabYing Xu, Yi Yang, Lu Li, et al.Molecular and Clinical Oncology|March 21, 2014
Dose-finding study on adjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancerLin Yang, Yi Yang, Qiong Qin, et al.Pageof 14